Exactly, a licensing deal for certain countries with 40 million up front and 15 million in stock bought at a higher rate, sounds like a good way to open a market, 245 million if you do well in sales. Problems are Qiru is does a lot of generic drug manufacturing and sales, so stealing LL could be a problem, counting sales to get royalties could be a problem. Not much money up front, we would need a better deal.